Ventas (VTR) news
Recent news
Ventas Inc: Mizuho raises target price to $104 from $98
AInvest Wire · Jul 22, 2026Moody's Ratings announces completion of a periodic review of ratings of Ventas Inc.
Moody's Ratings has completed a periodic review of the ratings assigned to Ventas Inc., a leading real estate investment trust (REIT) focused on healthcare properties. As part of this review, Moody's has affirmed Ventas's Baa1 credit rating, which reflects the company's strong operational…
AInvest Wire · Jun 23, 2026Ventas names Andrew L. Wattula EVP outpatient medical & research
Ventas Inc. has announced the appointment of Andrew L. Wattula as Executive Vice President of Outpatient Medical and Research, effective immediately. Wattula brings over 15 years of experience in real estate operations and management, most recently serving as Chief Operating Officer at Hudson…
AInvest Wire · Jun 22, 2026Deutsche Bank raises target price to $100 from $95 for Ventas, Inc
Deutsche Bank has raised its price target for Ventas, Inc (VTR) to $100 from $95, reflecting a positive outlook on the real estate investment trust. The adjustment indicates the firm's confidence in Ventas' long-term growth potential and operational performance. The move aligns with broader market…
AInvest Wire · Jun 16, 2026Ventas issues business update and will participate in investor meetings at NAREIT’s REITWeek 2026 investor conference
AInvest Wire · Jun 1, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.